Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1020959]Researchers: Prof Gail Risbridger (Principal investigator)
Brief description Withdrawal of male hormones in men with prostate cancer is effective therapeutically because it causes cell death in most of the tumour. However the remaining cells (called castrate resistant cells), give rise to recurrent disease that inevitably kills the patient. This project aims to test if our compound will kill these cells and prevent recurrence or if it has any benefit for the patients who have incurable disease.
Funding Amount $AUD 531,689.97
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1020959
- PURL : https://purl.org/au-research/grants/nhmrc/1020959
